Biotech projects are emerging throughout the world. Semiconductor projects are scarce except in Asia and particularly China. Here are two project examples from our World Cleanroom Projects:

 Project Title: Shire

Revision Date: 6/1/2003
Entry Date: 6/1/2003

Startup Date: 2004
Country: Canada
City: Laval
Size:  
Product: pharmaceuticals and biotechnology
Address:  
Telephone: 44-1256-894-280
SIC Description: Pharmaceuticals
Description:
Shire Pharmaceuticals will invest CDN $28 million in the construction of a new global vaccine research center. The Centre will support the company's biologics business and will be located at Shire's current site in Laval. Completion is planned for 2004.

Project Title: Ultimate Semiconductor

Revision Date: 7/1/2003
Entry Date: 7/1/2003

Startup Date: 2004
Country: China
City: Shanghai / Jiading District
Size:  
Product: 6-inch wafer
Address:  
Telephone:  
SIC Description: Semiconductor
Description:
Malaysia's Ultimate Semiconductor is building a facility in the Jiading district of Shanghai, China, to produce 6-inch wafers using 0.35 micron technology. they plan to expand to 8-inch wafer production based on market demand. The plant will have a maximum annual production capacity of 600,000 wafers, with trial operations scheduled to begin in June 2004.

We track developments on a biweekly basis in the Updates to Cleanrooms: World Markets.

Here are several examples:

Europe

The Jenoptik technology group has received three orders from the pharmaceutical industry for a total volume of approximately 13 million euros. The project was awarded to Life Science Meissner+Wurst GmbH (LSMW), a company of the Jenoptik Group.

LSMW will engineer and coordinate the construction of a new biopharmaceutical facility in Vienna for Bohringer Ingelheim Austria. The facility will produce biopharmaceutical active agents.

LSMW will also engineer a new influenza vaccine production facility in the Netherlands for the Belgian company, Solvay.

In a third order, LSMW will validate the safety of the pharmaceuticals produced in the new facility of B. Braun in Melsungen, Germany. LSMW will document the proof that the production facility and its products will meet the high quality standards necessary in pharmaceutical production.

The University of Newcastle's INEX nanotechnology business arm is to expand its operation. The planned expansion is to 450 m² cleanroom with a new 150m² microbiology lab suite leading to a total of 600 m². New capabilities will be in surface micromachining (oxides, nitrides, polysilicon), bioengineering (cell culture facilities, protein engineering, tissue engineering, DNA engineering and analysis, spotter/arrayer systems), ceramic processing, glass micromachining, RIE, laser ablation, image reversal systems, focused ion beam and an upgrade to 150-mm cassette operation.

***

More than 30,000 forecasts of rooms, components, and consumables are constantly revised in the online Cleanrooms: World Market report. This provides the opportunity to link sales quotas to market share through this total market information.  It is the Integrated Approach to Sales and Marketing http://www.mcilvainecompany.com/Integrated%20services/int%20home.html .

We have a package which includes both World Cleanroom Projects and Cleanrooms: World Markets and includes the e-mailed biweekly Updates to each of your sales people. They should have both the project information and the size of the markets in their territories.  For the U.S. we have a separate segmentation which can also be included in the package.  Samples of all this are shown under “Cleanrooms” at www.mcilvainecompany.com .

Bob McIlvaine

847-784-0012

www.mcilvainecompany.com